Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Safe and efficacious use of recombinant human erythropoietin in malignancy

Drew Provan, Paul Greaves and Samir Agrawal
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.7-6-617
Clin Med December 2007
Drew Provan
Institute of Cell and Molecular Science, The Royal London Hospital
Roles: Clinical Senior Lecturer in Haematology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Greaves
Department of Haematological Oncology, St Bartholomew's Hospital (Queen Mary, University of London), London
Roles: Specialist Registrar in Haematology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samir Agrawal
Department of Haematological Oncology, St Bartholomew's Hospital (Queen Mary, University of London), London
Roles: Senior Lecturer/Honorary Consultant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Safe and efficacious use of recombinant human erythropoietin in malignancy
Paul Greaves, Samir Agrawal
Clinical Medicine Dec 2007, 7 (6) 617-620; DOI: 10.7861/clinmedicine.7-6-617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Safe and efficacious use of recombinant human erythropoietin in malignancy
Paul Greaves, Samir Agrawal
Clinical Medicine Dec 2007, 7 (6) 617-620; DOI: 10.7861/clinmedicine.7-6-617
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

CME: Clinical Practice and its Basis

  • Training good prescribers: what are the best methods?
  • The cutaneous manifestations of haematological malignancy
  • CME Renal medicine
Show more CME: Clinical Practice and its Basis

Haematology

  • From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia
  • Haematological manifestations of systemic disease
Show more Haematology

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians